Recent News

Aug 09, 2018

Stewardship / Resistance Scan for Aug 09, 2018

Antibiotic resistance in Australia
New antibiotic for pneumonia, skin infections
Ventilator-associated pneumonia risk factors
Autism and early antibiotic exposure
Jul 10, 2018

Stewardship / Resistance Scan for Jul 10, 2018

UK competition for AMR innovation
Funding for new gonorrhea drug
Antibiotic course for pneumonia
May 22, 2018

News Scan for May 22, 2018

More Nipah in India
New CARB-X support
Cameroon monkeypox outbreak
AAP on FluMist
Pneumonia vaccine in elderly
May 08, 2018

News Scan for May 08, 2018

UK guidance on UTIs
Chagas disease in Americas
Cholera vaccination in Bangladesh
Flu vaccine and infant pneumonia
Apr 30, 2018

News Scan for Apr 30, 2018

Universal flu vaccine funds
Pneumococcal vaccine failure
Saudi MERS deaths
Hospital-acquired malaria
Aspergillosis burden
Feb 13, 2018

News Scan for Feb 13, 2018

Trump budget proposal
Lassa fever response
Saudi Arabia MERS
UK lab accidents
Pneumonia in opioid users
Feb 09, 2018

Stewardship / Resistance Scan for Feb 09, 2018

Research agenda for antibiotic resistance
Antibiotics for aspiration pneumonitis
Stewardship in kids' pneumonia
Feb 02, 2018

Stewardship / Resistance Scan for Feb 02, 2018

Gram-negative pneumonia antibiotic
Antibiotic-resistant E coli
Jan 16, 2018

News Scan for Jan 16, 2018

Suspected Rift Valley fever
Avian flu in 5 nations
Dengvaxia reimbursement
Kids pneumonia criteria
Measles scare
Dec 18, 2017
Examining chest x-ray

New antibiotic combo may be option for hospital pneumonia

A phase 3 trial shows ceftazidime-avibactam "non-inferior" to meropenem.

Resources & Literature

Recent Literature

Agweyu A, Lilford RJ, English M, et al. Appropriateness of clinical severity classification of new WHO childhood pneumonia guidance: a multi-hospital, retrospective, cohort study. Lancet Glob Health 2017 Jan;6(1):e74-83

AHRQ. Pneumonia: hospital-level, risk-standardized payment associated with a 30-day episode of care for pneumonia. Jan 3, 2018

AlBarrak A, Alotaibi B, Yassin Y, et al. Proportion of  adult community-acquired pneumonia cases attributable to Streptococcus pneumoniae among Hajj pilgrims in 2016. Int J Infect Dis 2018 (published online Feb 20)

Ambroggio L, Mangeot C, Kurowski EM, et al. Guideline adoption for community-acquired pneumonia in the outpatient setting. Pediatrics 2018 Oct

Bellew S, Grijalva CG, Williams DJ, et al. Pneumococcal and Legionella urinary antigen tests in community-acquired pneumonia: prospective evaluation of indications for testing. Clin Infect Dis 2018 (published online Sep 28)

Bernaola E, Gil F, Herranz M, et al. Pneumococcal vaccination and pneumonia associated with pleural effusion in a pediatric population. Pediatr Infect Dis J 2018 Apr;37(4):e87-92

Castaneda-Orjuela C, De la Hoz-Restrepo F. How cost effective is switching universal vaccination from PCV10 to PVC13? a case study from a developing country. Vaccine 2018 (published online Aug 4)

Chen C, Beutels P, Wood J, et al. Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia. Vaccine 2018 (published online Sep 10)

Daniel P, Rodrigo C, Bewick T, et al. 13-valent vaccine serotype pneumococcal community acquired pneumonia in adults in high clinical risk groups. Vaccine 2018 (published online Feb 10)

Danino D, Givon-Lavi N, Ben-Shimol S, et al. Understanding the evolution of antibiotic-nonsusceptible pneumococcal nasopharyngeal colonization following pneumococcal conjugate vaccines implementation in young children. Clin Infect Dis 2018 (published online Oct 29)

Dean P, Florin TA. Factors associated with pneumonia severity in children: a systematic review.  J Pediatric Infect Dis Soc 2018 (published online May 30)

Dendle C, Stuart RL, Mulley WR, et al. Pneumococcal vaccination in adult solid organ transplant recipients: a review of current evidence. Vaccine 2018 (published online Sep 11)

Dunne EM, Satzke C, Ratu FT, et al. Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys. Lancet Glob Health 2018 Dec 1;6(12):pe1375-85

Eythorsson E, Sigurdsson S, Hrafnkelsson B, et al. Impact of the 10-valent pneumococcal conjugate vaccine on antimicrobial prescriptions in young children: a whole population study. BMC Infect Dis 2018 Oct 4;18:505

Florin TA, Brokamp C, Mantyla R, et al. Validation of the PIDS/IDSA severity criteria in children with community-acquired pneumonia. Clin Infect Dis 2018 (published online Jan 13)

Goldblatt D, Southern J, Andrews NJ, et al. Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1+1) compared with two primary doses and a booster (2+1) in UK infants: a multicentre, parallel group randomised controlled trial. Lancet Infect Dis 2017 (published online Nov 22)

Gothankar J, Doke P, Dhumale G, et al. Reported incidence and risk factors of childhood pneumonia in India: a community-based cross-sectional study. BMC Public Health 2018 Sep 11;18:111

Greenberg D, Hoover PA, Vesikari T, et al. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. Vaccine 2018 (published online Sep 21)

Heinsbroek E, Tafatatha T, Phiri A, et al. Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination. Vaccine 2018 (published online Oct 21)

Jayasinghe S, Chiu C, Quinn H, et al. Effectiveness of seven and thirteen valent pneumococcal conjugate vaccines in a schedule without a booster dose: a ten year observational study. Clin Infect Dis 2018 (published online Feb 17)

Kalkowska DA, Boender GJ, Smit LAM, et al. Associations between pneumonia and residential distance to livestock farms over a five-year period in a large population-based study. PLoS One 2018 Jul 17;13(7):e0200813

Kambire D, Soeters HM, Ouedraogo-Traore R, et al. Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis — Burkina Faso, 2014-2015. J Infect 2017 (published online Dec 15)

Karimata Y, Kinjo T, Parrott G, et al. Clinical features of human metapneumovirus pneumonia in non-immunocompromised patients: an investigation of three long-term care facility outbreaks. J Infect Dis 2018 (published online May 4)

Kilpi TM, Jokinen J, Puumalainen T, et al. Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: a cluster-randomised trial. Vaccine 2018 (published online Aug 23)

Kim JH, Baik SH, Chun BC, et al. Adult invasive pneumococcal disease in the Republic of Korea: risk medical conditions and mortality stratified to age groups. Int J Infect Dis 2018 (published online Jul 25)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead Become an underwriter»